TGA Approval

NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe (312652)

ARTG ID

312652

ARTG Name

NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe

Sponsor

GlaxoSmithKline Australia Pty Ltd

ARTG Date

December 2, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

GLAXOSMITHKLINE AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-02418-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-01215-1

Ingredient Name

Mepolizumab

Empowering clinical research with data-driven insights and AI-powered tools.

NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe (312652) - TGA 批准文号 | MedPath